Skip to main navigation Skip to search Skip to main content

CTU: A Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BNT327 or DB-1305 in Participants with Advanced/Metastatic Solid Tumors

  • Parsonson, Andrew (Primary Chief Investigator)
  • Quinlan, Gabriel (Clinical Trial Unit Staff)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Martin, Lewis (Clinical Trial Unit Staff)
  • TAIDI, Gina (Clinical Trial Unit Staff)
  • Garcia, Michelle (Clinical Trial Unit Staff)
  • Armstrong, Emilia (Clinical Trial Unit Staff)
  • Lawrie, Angus (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleDB-1311-201
StatusActive
Effective start/end date19/08/2518/08/30